Manuela Las‐Jankowska

868 total citations
19 papers, 61 citations indexed

About

Manuela Las‐Jankowska is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Manuela Las‐Jankowska has authored 19 papers receiving a total of 61 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Manuela Las‐Jankowska's work include Colorectal Cancer Surgical Treatments (5 papers), Colorectal and Anal Carcinomas (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Manuela Las‐Jankowska is often cited by papers focused on Colorectal Cancer Surgical Treatments (5 papers), Colorectal and Anal Carcinomas (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Manuela Las‐Jankowska collaborates with scholars based in Poland, Hungary and Italy. Manuela Las‐Jankowska's co-authors include Michał Jankowski, Wojciech Zegarski, Joanna Streb, Anna Klimczak, Marcin Ziętek, W. Zegarski, Renata Pacholczak‐Madej, Andrzej Rutkowski, Tomasz Olesiński and Czesław Osuch and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Manuela Las‐Jankowska

13 papers receiving 60 citations

Peers

Manuela Las‐Jankowska
Yasushi Rino Japan
Lara Ugoletti Italy
Juan Antonio Virizuela Echaburu Spain
Fabiana Sousa Portugal
Kazuhiro Ishimaru Japan
Éamon P McCarron United Kingdom
Eszter Katona United Kingdom
Javier Rodríguez Spain
Huayi Liu China
Teresa Perra Italy
Yasushi Rino Japan
Manuela Las‐Jankowska
Citations per year, relative to Manuela Las‐Jankowska Manuela Las‐Jankowska (= 1×) peers Yasushi Rino

Countries citing papers authored by Manuela Las‐Jankowska

Since Specialization
Citations

This map shows the geographic impact of Manuela Las‐Jankowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Las‐Jankowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Las‐Jankowska more than expected).

Fields of papers citing papers by Manuela Las‐Jankowska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Las‐Jankowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Las‐Jankowska. The network helps show where Manuela Las‐Jankowska may publish in the future.

Co-authorship network of co-authors of Manuela Las‐Jankowska

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Las‐Jankowska. A scholar is included among the top collaborators of Manuela Las‐Jankowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Las‐Jankowska. Manuela Las‐Jankowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Püsküllüoğlu, Mirosława, Anna Polakiewicz-Gilowska, Iveta Selingerová, et al.. (2025). 566P Effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer: A real-world retrospective cohort study from central Europe. Annals of Oncology. 36. S419–S419.
2.
3.
Polakiewicz-Gilowska, Anna, Manuela Las‐Jankowska, Michał Jarząb, et al.. (2025). Assessment of weight change and BMI as prognostic markers of survival outcomes in sacituzumab govitecan therapy for mTNBC in a Polish female cohort.. Journal of Clinical Oncology. 43(16_suppl).
4.
Püsküllüoğlu, Mirosława, Joanna Streb, Manuela Las‐Jankowska, et al.. (2025). Abstract P4-05-02: Strategies for premedication and neutropenia prophylaxis in sacituzumab govitecan treatment of patients with triple-negative breast cancer: multicenter insights. Clinical Cancer Research. 31(12_Supplement). P4–5. 1 indexed citations
5.
Polakiewicz-Gilowska, Anna, Manuela Las‐Jankowska, Michał Jarząb, et al.. (2025). Hemoglobin level and neutrophil-to-lymphocyte ratio as prognostic peripheral blood markers of survival outcomes in sacituzumab govitecan therapy for mTNBC in Polish female cohort.. Journal of Clinical Oncology. 43(16_suppl).
6.
Polakiewicz-Gilowska, Anna, Manuela Las‐Jankowska, Michał Jarząb, et al.. (2025). Weight change and BMI are not prognostic markers of survival outcomes in sacituzumab govitecan therapy for mTNBC in the Polish female cohort. Therapeutic Advances in Medical Oncology. 17. 22807840–22807840.
7.
Püsküllüoğlu, Mirosława, Manuela Las‐Jankowska, Joanna Streb, et al.. (2024). Sacituzumab Govitecan for Second and Subsequent Line Palliative Treatment of Patients with Triple-Negative Breast Cancer: A Polish Real-World Multicenter Cohort Study. Oncology and Therapy. 12(4). 787–801. 2 indexed citations
8.
Ziętek, Marcin, Paweł Teterycz, Michał Jankowski, et al.. (2023). The Current Treatment Trends and Survival Patterns in Melanoma Patients with Positive Sentinel Lymph Node Biopsy (SLNB): A Multicenter Nationwide Study. Cancers. 15(10). 2667–2667. 4 indexed citations
9.
Pacholczak‐Madej, Renata, et al.. (2023). Relationship of adverse events after combined immunotherapy and treatment outcomes in patients with advanced melanoma: A multicenter experience in Poland.. Journal of Clinical Oncology. 41(16_suppl). e21511–e21511. 2 indexed citations
10.
Pacholczak‐Madej, Renata, Mirosława Püsküllüoğlu, Manuela Las‐Jankowska, et al.. (2022). Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience. Biomedicines. 10(10). 2528–2528. 5 indexed citations
11.
12.
Jankowski, Michał, et al.. (2021). Clinical Reality and Treatment for Local Recurrence of Rectal Cancer: A Single-Center Retrospective Study. Medicina. 57(3). 286–286. 8 indexed citations
13.
Jankowski, Michał, et al.. (2020). Overall treatment outcome – analysis of long-term results of rectal cancer treatment on the basis of a new parameter. Archives of Medical Science. 16(4). 825–833. 2 indexed citations
14.
Rutkowski, Piotr, Marcin Ziętek, Bożena Cybulska-Stopa, et al.. (2020). The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice. European Journal of Surgical Oncology. 47(5). 1191–1195. 12 indexed citations
15.
Lewandowska, Marzena Anna, et al.. (2019). Detection of somatic mutations in ctDNA derived from adenocarcinoma patients – EGFR tyrosine kinase inhibitor monitoring preliminary study. Współczesna Onkologia. 23(2). 87–91. 1 indexed citations
16.
Jankowski, Michał, et al.. (2018). Contemporary enteral and parenteral nutrition before surgery for gastrointestinal cancers: a literature review. World Journal of Surgical Oncology. 16(1). 94–94. 17 indexed citations
17.
Jankowski, Michał, et al.. (2018). The role of postoperative chemotherapy in patients who undergoing surgery following chemoradiotherapy of initially unresectable rectal cancer. Nowotwory Journal of Oncology. 67(5). 281–284. 1 indexed citations
18.
Jankowski, Michał, et al.. (2016). 333. Local recurrence after neoadjuvant radiotherapy resectable locoregional advanced rectal cancer. European Journal of Surgical Oncology. 42(9). S150–S151. 1 indexed citations
19.
Nowikiewicz, Tomasz, et al.. (2014). Management and results of treatment of breast cancer patients having sentinel lymph node micrometastases. Neoplasma. 61(3). 299–304. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasushi Rino Breakdown of academic impact, for papers by Lara Ugoletti Breakdown of academic impact, for papers by Juan Antonio Virizuela Echaburu Breakdown of academic impact, for papers by Fabiana Sousa Breakdown of academic impact, for papers by Kazuhiro Ishimaru Breakdown of academic impact, for papers by Éamon P McCarron Breakdown of academic impact, for papers by Eszter Katona Breakdown of academic impact, for papers by Javier Rodríguez Breakdown of academic impact, for papers by Huayi Liu Breakdown of academic impact, for papers by Teresa Perra
Rankless by CCL
2026